发明名称 IFN-alpha and amantadine for treating hepatitis C
摘要 The present invention provides a method for treating chronic hepatitis C infections in patients in need of such treatment comprising administering an amount of IFN-alpha in association with an amount of amantadine effective to treat hepatitis C. In accordance with the invention, IFN-alpha and amantadine are administered at the same time or sequentially. The present invention also provides a kit for treating a hepatitis C infection containing IFN-alpha and amantadine in suitable dosage forms for administering the combination therapy.
申请公布号 US2003031647(A1) 申请公布日期 2003.02.13
申请号 US20020236268 申请日期 2002.09.06
申请人 ZAHM FRIEDERIKE 发明人 ZAHM FRIEDERIKE
分类号 A61K38/21;A61P1/16;A61P31/12;(IPC1-7):A61K38/21;A61K31/13 主分类号 A61K38/21
代理机构 代理人
主权项
地址